The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Oxidative Stress in Alzheimer’s Disease: Why Did Antioxidant Therapy Fail?
Open accessAbstract
Alzheimer’s disease (AD) is the most common form of dementia in the elderly, with increasing prevalence and no disease-modifying treatment available yet. A remarkable amount of data supports the hypothesis that oxidative stress is an early and important pathogenic operator in AD. However, all clinical studies conducted to date did not prove a clear beneficial effect of antioxidant treatment in AD patients. In the current work, we review the current knowledge about oxidative stress in AD pathogeny and we suggest future paths that are worth to be explored in animal models and clinical studies, in order to get a better approach of oxidative imbalance in this inexorable neurodegenerative disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
Protein Oxidation in Aging, Disease, and Oxidative Stress
Berlett, B. S., & Stadtman, E. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20313 · Cited by 3,332
Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1
Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., & Ichijo, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2596 · Cited by 2,377
Brain energy metabolism: focus on Astrocyte-neuron metabolic cooperation
Bélanger, M., Allaman, I., & Magistretti, P. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.016 · Cited by 2,313
8-hydroxy-2′ -deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis
VALAVANIDIS, A., VLACHOGIANNI, T., & FIOTAKIS, C. (2009) · Journal of Environmental Science and Health, Part C · doi:10.1080/10590500902885684 · Cited by 1,978
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., & Mayeux, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03356-9 · Cited by 1,647
Vitamin E: function and metabolism
Brigelius‐Flohé, R., & Traber, M. G. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1145 · Cited by 1,591
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037
Mulnard, R. A., Cotman, C. W., Kawas, C., van Dyck, C. H., Sano, M., Doody, R., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1007 · Cited by 991
Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779
Miyata, M., & Smith, J. D. (1996) · Nature Genetics · doi:10.1038/ng0996-55 · Cited by 735
Neuropathologic changes in Alzheimer's disease.
Wenk, G. L. (2003) · PubMed · Cited by 709
Oxidative stress in the progression of Alzheimer disease in the frontal cortex
Ansari, M. A., & Scheff, S. W. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181cb5af4 · Cited by 605
Begum, A. N., Jones, M. R., Lim, G. P., Morihara, T., Kim, P., Heath, D. D., Rock, C. L., Pruitt, M. A., Yang, F., Hudspeth, B., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137455 · Cited by 604
Baum, L., Lam, C. W. K., Cheung, S. K.-K., Kwok, T., Lui, V., Tsoh, J., Lam, L., Leung, V., Hui, E., Ng, C., et al. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160862c · Cited by 592
Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease
Rinaldi, P., Polidori, M. C., Metastasio, A., Mariani, E., Mattioli, P., Cherubini, A., Catani, M., Cecchetti, R., Senin, U., & Mecocci, P. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00031-9 · Cited by 549
Ringman, J. M., Frautschy, S. A., Teng, E., Begum, A. N., Bardens, J., Beigi, M., Gylys, K. H., Badmaev, V., Heath, D. D., Apostolova, L. G., et al. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt146 · Cited by 541
Ma, Q.-L., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., Chen, P. P., Hudspeth, B., Chen, C., Zhao, Y., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1071-09.2009 · Cited by 536
Pulla Reddy, A. C., & Lokesh, B. R. (1992) · Molecular and Cellular Biochemistry · doi:10.1007/bf00229582 · Cited by 458
Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease
Wang, J., Xiong, S., Xie, C., Markesbery, W. R., & Lovell, M. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03053.x · Cited by 451
Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures
Lovell, M. A., Xie, C., & Markesbery, W. R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00235-9 · Cited by 450
Ribosome Dysfunction Is an Early Event in Alzheimer's Disease
Ding, Q., Markesbery, W. R., Chen, Q., Li, F., & Keller, J. N. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3040-05.2005 · Cited by 433
Stadelmann, C., Deckwerth, T. L., Srinivasan, A., Bancher, C., Brück, W., Jellinger, K., & Lassmann, H. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65460-0 · Cited by 428
Mammalian Mitochondrial Complex I: Biogenesis, Regulation, and Reactive Oxygen Species Generation
Koopman, W. J. H., Nijtmans, L. G. J., Dieteren, C. E. J., Roestenberg, P., Valsecchi, F., Smeitink, J. A. M., & Willems, P. H. G. M. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2743 · Cited by 411
Increased F 2 ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo
Pratico, D., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & Fitzgerald, G. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1777 · Cited by 405
Vellas, B., Coley, N., Ousset, P.-J., Berrut, G., Dartigues, J.-F., Dubois, B., Grandjean, H., Pasquier, F., Piette, F., Robert, P., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70206-5 · Cited by 398
Padurariu, M., Ciobica, A., Hritcu, L., Stoica, B., Bild, W., & Stefanescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.033 · Cited by 378
Galasko, D. R., Peskind, E., Clark, C. M., Quinn, J. F., Ringman, J. M., Jicha, G. A., Cotman, C., Cottrell, B., Montine, T. J., Thomas, R. G., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.85 · Cited by 377
Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease
Resende, R., Moreira, P. I., Proença, T., Deshpande, A., Busciglio, J., Pereira, C., & Oliveira, C. R. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.012 · Cited by 343
Causes of oxidative stress in Alzheimer disease
Zhu, X., Su, B., Wang, X., Smith, M. A., & Perry, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7218-4 · Cited by 336
Snitz, B. E. (2009) · JAMA · doi:10.1001/jama.2009.1913 · Cited by 336
F2-Isoprostanes as markers of oxidative stress in vivo: An overview
Milne, G. L., Musiek, E. S., & Morrow, J. D. (2005) · Biomarkers · doi:10.1080/13547500500216546 · Cited by 312
Misonou, H., Morishima-Kawashima, M., & Ihara, Y. (2000) · Biochemistry · doi:10.1021/bi000169p · Cited by 304
Lovell, M. A., Gabbita, S. P., & Markesbery, W. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720771.x · Cited by 291
Benzi, G., & Moretti, A. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00244-e · Cited by 283
Microtubule-Associated Protein Tau
Yen, S.-H., Nacharaju, P., Ko, L.-W., Kenessey, A., & Liu, W.-K. (1998) · Handbook of the Aging Brain · doi:10.1016/b978-012734610-6/50012-9 · Cited by 282
Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment
Markesbery, W. R., Kryscio, R. J., Lovell, M. A., & Morrow, J. D. (2005) · Annals of Neurology · doi:10.1002/ana.20629 · Cited by 273
Marszalek, J. R., & Lodish, H. F. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120624 · Cited by 270
Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients
Migliore, L., Fontana, I., Trippi, F., Colognato, R., Coppedè, F., Tognoni, G., Nucciarone, B., & Siciliano, G. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.016 · Cited by 263
ABAD enhances Aβ‐induced cell stress via mitochondrial dysfunction
Takuma, K., Yao, J., Huang, J., Xu, H., Chen, X., Luddy, J., Trillat, A.-C., Stern, D. M., Arancio, O., & Yan, S. S. (2005) · The FASEB Journal · doi:10.1096/fj.04-2582fje · Cited by 252
Increased CSF F 2 -isoprostane concentration in probable AD
Montine, T. J., Beal, M. F., Cudkowicz, M. E., O’Donnell, H., Margolin, R. A., McFarland, L., Bachrach, A. F., Zackert, W. E., Roberts, L. J., & Morrow, J. D. (1999) · Neurology · doi:10.1212/wnl.52.3.562 · Cited by 251
Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people
DiSilvestro, R. A., Joseph, E., Zhao, S., & Bomser, J. (2012) · Nutrition Journal · doi:10.1186/1475-2891-11-79 · Cited by 243
Ahmed, N., Ahmed, U., Thornalley, P. J., Hager, K., Fleischer, G., & Münch, G. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02864.x · Cited by 238
Peripheral Oxidative Stress Biomarkers in Mild Cognitive Impairment and Alzheimer's Disease
Torres, L. L., Quaglio, N. B., de Souza, G. T., Garcia, R. T., Dati, L. M. M., Moreira, W. L., de Melo Loureiro, A. P., de souza-Talarico, J. N., Smid, J., Porto, C. S., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110284 · Cited by 234
Calabrese, V., Sultana, R., Scapagnini, G., Guagliano, E., Sapienza, M., Bella, R., Kanski, J., Pennisi, G., Mancuso, C., Stella, A. M. G., et al. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1975 · Cited by 227
RNA modifications by oxidation: A novel disease mechanism?
Poulsen, H. E., Specht, E., Broedbaek, K., Henriksen, T., Ellervik, C., Mandrup-Poulsen, T., Tonnesen, M., Nielsen, P. E., Andersen, H. U., & Weimann, A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.009 · Cited by 212
Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply
SCHWEIZER, U., STRECKFUß, F., PELT, P., CARLSON, B. A., HATFIELD, D. L., KÖHRLE, J., & SCHOMBURG, L. (2005) · Biochemical Journal · doi:10.1042/bj20041973 · Cited by 207
Alderson, N. L., Wang, Y., Blatnik, M., Frizzell, N., Walla, M. D., Lyons, T. J., Alt, N., Carson, J. A., Nagai, R., Thorpe, S. R., et al. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.03.005 · Cited by 202
Decreased thioredoxin and increased thioredoxin reductase levels in alzheimer’s disease brain
Lovell, M. A., Xie, C., Gabbita, S. P., & Markesbery, W. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00258-0 · Cited by 202
Kwong, L. K., Kamzalov, S., Rebrin, I., Bayne, A.-C. V., Jana, C. K., Morris, P., Forster, M. J., & Sohal, R. S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00916-4 · Cited by 198
Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease Brain
Ramassamy, C., Averill, D., Beffert, U., Theroux, L., Lussier-Cacan, S., Cohn, J. S., Christen, Y., Schoofs, A., Davignon, J., & Poirier, J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0273 · Cited by 195
Involvement of glutaredoxin-1 and thioredoxin-1 in β-amyloid toxicity and Alzheimer's disease
Akterin, S., Cowburn, R. F., Miranda-Vizuete, A., Jiménez, A., Bogdanovic, N., Winblad, B., & Cedazo-Minguez, A. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401818 · Cited by 182
Self-citationSelenium and Alzheimer's Disease: A Systematic Review
Loef, M., Schrauzer, G. N., & Walach, H. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110414 · Cited by 181
Plasma Selenium Over Time and Cognitive Decline in the Elderly
Akbaraly, N. T., Hininger-Favier, I., Carri??re, I., Arnaud, J., Gourlet, V., Roussel, A.-M., & Berr, C. (2007) · Epidemiology · doi:10.1097/01.ede.0000248202.83695.4e · Cited by 178
Paola, D., Domenicotti, C., Nitti, M., Vitali, A., Borghi, R., Cottalasso, D., Zaccheo, D., Odetti, P. R., Strocchi, P., Marinari, U. M., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2164 · Cited by 177
Zeng, J., & Davies, M. J. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050074u · Cited by 173
The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats
Bridi, R., Crossetti, F. P., Steffen, V. M., & Henriques, A. T. (2001) · Phytotherapy Research · doi:10.1002/ptr.814 · Cited by 172
Nadeau, P. J., Charette, S. J., Toledano, M. B., & Landry, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0491 · Cited by 171
Tocopherols and tocotrienols plasma levels are associated with cognitive impairment
Mangialasche, F., Xu, W., Kivipelto, M., Costanzi, E., Ercolani, S., Pigliautile, M., Cecchetti, R., Baglioni, M., Simmons, A., Soininen, H. S., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.019 · Cited by 167
Greilberger, J., Koidl, C., Greilberger, M., Lamprecht, M., Schroecksnadel, K., Leblhuber, F., Fuchs, D., & Oettl, K. (2008) · Free Radical Research · doi:10.1080/10715760802255764 · Cited by 167
Hydrogen Peroxide Promotes Aβ Production through JNK-dependent Activation of γ-Secretase
Shen, C., Chen, Y., Liu, H., Zhang, K., Zhang, T., Lin, A., & Jing, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800013200 · Cited by 167
Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal
Doorn, J. A., & Petersen, D. R. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00178-3 · Cited by 164
High Plasma Levels of Vitamin E Forms and Reduced Alzheimer's Disease Risk in Advanced Age
Mangialasche, F., Kivipelto, M., Mecocci, P., Rizzuto, D., Palmer, K., Winblad, B., & Fratiglioni, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091450 · Cited by 158
Peripheral Oxidative Damage in Mild Cognitive Impairment and Mild Alzheimer's Disease
Baldeiras, I., Santana, I. J., Proença, M. T., Garrucho, M. H., Pascoal, R., Rodrigues, A. P., Duro, D., & Oliveira, C. R. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15110 · Cited by 157
Peripheral F2‐isoprostanes and F4‐neuroprostanes are not increased in Alzheimer's disease
Montine, T. J., Quinn, J. F., Milatović, D., Silbert, L. C., Dang, T. N. T., Sanchez, S. C., Terry, E. S., Roberts, L. J., Kaye, J. A., & Morrow, J. D. (2002) · Annals of Neurology · doi:10.1002/ana.10272 · Cited by 157
Idebenone treatment fails to slow cognitive decline in Alzheimer’s disease
Thal, L. J., Grundman, M., Berg, J., Ernstrom, K., Margolin, R., Pfeiffer, E., Weiner, M. F., Zamrini, E., & Thomas, R. G. (2003) · Neurology · doi:10.1212/01.wnl.0000096376.03678.c1 · Cited by 156
Karuppagounder, S. S., Xu, H., Shi, Q., Chen, L. H., Pedrini, S., Pechman, D., Baker, H., Beal, M. F., Gandy, S., & Gibson, G. E. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.013 · Cited by 155
Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia
Puertas, M. C., Martínez-Martos, J. M., Cobo, M., Carrera-González, M. P., Mayas, M. D., & Ramírez-Expósito, M. J. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.05.019 · Cited by 153
Headlam, H. A., & Davies, M. J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.02.017 · Cited by 148
Paola, D., Domenicotti, C., Nitti, M., Vitali, A., Borghi, R., Cottalasso, D., Zaccheo, D., Odetti, P. R., Strocchi, P., Marinari, U. M., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2756 · Cited by 146
Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis
Ricci, C., Pastukh, V. M., Leonard, J. N., Turrens, J. F., Wilson, G. L., Schaffer, D., & Schaffer, S. W. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00362.2007 · Cited by 145
Glutathione relates to neuropsychological functioning in mild cognitive impairment
Duffy, S. L., Lagopoulos, J., Hickie, I. B., Diamond, K., Graeber, M. B., Lewis, S. J. G., & Naismith, S. L. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.005 · Cited by 138
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124
Abe, T., Tohgi, H., Isobe, C., Murata, T., & Sato, C. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10349 · Cited by 124
Bilikiewicz, A., & Gaus, W. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6103 · Cited by 124
Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain
Lovell, M. A., Soman, S., & Bradley, M. A. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.08.003 · Cited by 124
Kuhla, B., Haase, C., Flach, K., Lüth, H.-J., Arendt, T., & Münch, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609521200 · Cited by 119 · cited 1×
“Acrolein is an example of such an aldehydic lipid peroxidation product that is increased in AD brains [30] and can create damage to mitochondria by inhibiting respiration andmodulating tau phosphorylation [31].”
Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression
Bradley‐Whitman, M. A., Xiong, S., Markesbery, W. R., & Lovell, M. A. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.016 · Cited by 119
Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer's disease
Kadıoğlu, E., Şardaş, S., Aslan, S., Işık, E., & Karakaya, A. E. (2004) · Biomarkers · doi:10.1080/13547500410001728390 · Cited by 118
Rukhsana Sultana, A., Piroddi, M., Galli, F., & Butterfield, D. A. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9593-0 · Cited by 117
Cenini, G., Sultana, R., Memo, M., & Butterfield, D. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00163.x · Cited by 117
4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells
Sharma, A., Sharma, R., Chaudhary, P., Vatsyayan, R., Pearce, V., Jeyabal, P., Zimniak, P., Awasthi, S., & Awasthi, S. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.09.016 · Cited by 114
Truncated Thioredoxin: Physiological Functions and Mechanism
Pekkari, K., & Holmgren, A. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604771978345 · Cited by 113
Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease
Jiménez‐Jiménez, F. J., de Bustos, F., Molina, J. A., Benito‐León, J., Tallón-Barranco, A., Gasalla, T., Pareja, M. O., Guillamón, F., Rubio‐Terres, C., Arenas, J., et al. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291887 · Cited by 112
Liu, T., Stern, A., Roberts, L. J., & Morrow, J. D. (1999) · Journal of Biomedical Science · doi:10.1007/bf02253564 · Cited by 109
Arlt, S., Müller‐Thomsen, T., Beisiegel†, U., & Kontush, A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0860-8 · Cited by 101
Xiang, Z., Haroutunian, V., Ho, L., Purohit, D., & Pasinetti, G. M. (2006) · Disease Markers · doi:10.1155/2006/276239 · Cited by 101
Głodzik-Sobańska, L., Pirraglia, E., Bryś, M., Santi, S. D., Mosconi, L., Rich, K. E., Switalski, R., Louis, L. S., Sadowski, M. J., Martiniuk, F. T., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.019 · Cited by 95
Chan, A., Remington, R., Kotyla, E., Lepore, A., Zemianek, J. M., & Shea, T. B. (2010) · The journal of nutrition health & aging · doi:10.1007/s12603-010-0054-5 · Cited by 86
Albrecht, S., Bogdanović, N., Ghetti, B. F., Winblad, B. G., & LeBlanc, A. C. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c1da10 · Cited by 80
Arnim, C. A. F. V., the ActiFE Ulm study group, Herbolsheimer, F., Nikolaus, T., Peter, R., Biesalski, H. K., Ludolph, A. C., Riepe, M. W., & Nagel, G. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120634 · Cited by 69
Plasma F2A Isoprostane Levels in Alzheimer’s and Parkinson’s Disease
Irizarry, M. C., Yao, Y., Hyman, B. T., Growdon, J. H., & Praticò, D. (2007) · Neurodegenerative Diseases · doi:10.1159/000107699 · Cited by 68
Schönknecht, P., Pantel, J., Klinga, K., et al. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01896-1 · Cited by 66
Selkoe, D. J. (1989) · Annals of Medicine · doi:10.3109/07853898909149187 · Cited by 66
Terada, A., Yoshida, M., Seko, Y., Kobayashi, T., Yoshida, K., Nakada, M., Nakada, K., Echizen, H., Ogata, H., & Rikihisa, T. (1999) · Nutrition · doi:10.1016/s0899-9007(99)00119-7 · Cited by 61
For the Select Investigators, Kryscio, R. J., Abner, E. L., Schmitt, F. A., Goodman, P. J., Mendiondo, M. S., Caban‐Holt, A., Dennis, B., Mathews, M. J., Klein, E. A., et al. (2012) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0083-3 · Cited by 58
Vitamin E and selenium supplementation in geriatric patients
Tolonen, M., Halme, M., & Sarna, S. J. (1985) · Biological Trace Element Research · doi:10.1007/bf02916538 · Cited by 57
Sinem, F., Konukoğlu, D., Gokhan, E., Melda, B., Orhan, Y., & Filiz, M. (2010) · Current Alzheimer Research · doi:10.2174/156720510791383822 · Cited by 54
Gil-Bea, F. J., Akterin, S., Persson, T., Mateos, L., Matton, A., Avila‐Cariño, J., Gutiérrez-Rodríguez, A., Sundström, E., Holmgren, A., Winblad, B. G., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201462 · Cited by 52
Self-citationLeszek, J., Inglot, A. D., Janusz, M., Byczkiewicz, F., Kiejna, A., Georgiades, J. A., & Lisowski, J. (2002) · PubMed · Cited by 47
Enzymatic antioxidant balance and cognitive decline in aging — the EVA study
Berr, C., Richard, M., Gourlet, V., Garrel, C., & Favier, A. E. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000017830.27594.e9 · Cited by 46
Proline-rich polypeptide (PRP)--an immunomodulatory peptide from ovine colostrum.
Janusz, M., & Lisowski, J. (1993) · PubMed · Cited by 43
Lü, C., Zhang, D., Whiteman, M., & Armstrong, J. S. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1865 · Cited by 40
Yamamoto, H., Ozaki, T., Nakanishi, M., Kikuchi, H., Yoshida, K., Horie, H., Kuwano, H., & Nakagawara, A. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01065.x · Cited by 37
Mateos, L., Persson, T., Katoozi, S., Gil-Bea, F. J., & Cedazo-Mı́nguez, Á. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.11.016 · Cited by 35
Self-citationModulation of 4HNE-Mediated Signaling by Proline-Rich Peptides from Ovine Colostrum
Boldogh, I. R., Liebenthal, D. A., Hughes, T. K., Juelich, T. L., Georgiades, J. A., Kruzel, M. L., & Stanton, G. J. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:2:125 · Cited by 32
Cedazo-Mínguez, Á., & Cowburn, R. F. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02761-2 · Cited by 17
Dolatabadi, H. R. D., Reisi, P., Alaei, H., Azizi-Malekabadi, H., & Pilehvarian, A. A. (2012) · PubMed Central · Cited by 17
Effect of the Proline-Rich Polypeptide Complex/Colostrinin™ on the Enzymatic Antioxidant System
Zabłocka, A., & Janusz, M. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0187-9 · Cited by 12
Cited by
The role of antioxidants in the chemistry of oxidative stress: A review
Pisoschi, A. M., & Pop, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.040 · Cited by 2,806
Lipid peroxidation in cell death
Gaschler, M. M., & Stockwell, B. R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.086 · Cited by 1,828
Targeting Free Radicals in Oxidative Stress-Related Human Diseases
Poprac, P., Jomova, K., Simunkova, M., Kollar, V., Rhodes, C. J., & Valko, M. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.005 · Cited by 1,107
Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease
Bai, R., Guo, J., Ye, X.-Y., Xie, Y., & Xie, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101619 · Cited by 813
Alzheimer’s disease hypothesis and related therapies
Du, X., Wang, X., & Geng, M. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0107-y · Cited by 607
Metadata
- Authors
- Persson, T., Popescu, B. O., & Cedazo-Minguez, A.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-11
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W1997288864
- Cited by
- 312
- References
- 114
- FWCI
- 13.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.